These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4127854)

  • 1. [Prevention and depression of experimental allergic encephalomyelitis by the administration of brain antigens and barbamyl].
    Reber NV
    Patol Fiziol Eksp Ter; 1973; 17(1):65-7. PubMed ID: 4127854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suppression of experimental allergic encephalomyelitis with vaccinia-virus-induced anti-brain antibodies (author's transl)].
    Simon J; Hochstein-Mintzel V; Huber HC; Gradl A; Hansert E
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):23-35. PubMed ID: 68632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of chronic-relapsing EAE by basic protein-liposome complexes.
    Strejan GH; Gilbert JJ; St Louis J
    Prog Clin Biol Res; 1984; 146():429-34. PubMed ID: 6201911
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats.
    Swanborg RH; Swierkosz JE; Saieg RG
    J Immunol; 1974 Feb; 112(2):594-600. PubMed ID: 4130692
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Tabira T; Itoyama Y; Kuroiwa Y
    Prog Clin Biol Res; 1984; 146():43-8. PubMed ID: 6201912
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1974 Jan; 112(1):392-7. PubMed ID: 4130152
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of development of experimental allergic encephalomyelitis by encephalitogenic protein].
    Zhitnukhin IuL; Sofronov BN; Beme DKh; Baĭkovskaia MN
    Patol Fiziol Eksp Ter; 1978; (5):55-60. PubMed ID: 83596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disordered permeability of the hemato-encephalic barrier in the development of allergic processes of the nervous system].
    Zhitnukhin IuL; Sofronov BN
    Patol Fiziol Eksp Ter; 1989; (5):44-7. PubMed ID: 2482476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous allergic sensitivity in experimental allergic encephalomyelitis].
    Zhitnukhin IuL
    Biull Eksp Biol Med; 1973 Jun; 75(6):82-6. PubMed ID: 4778346
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of experimental allergic encephalomyelitis caused by sensitization with Bordetella pertussis combined with cerebral tissue].
    Kanchurin AKh; Kapitonova ME
    Biull Eksp Biol Med; 1971 Sep; 72(9):73-7. PubMed ID: 4329604
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-inflammatory expression of fibronectin (Fn) and Ia in acute experimental allergic encephalomyelitis (EAE): modulation of endothelial cells (EC) in the immune response detected by quantitative immunoperoxidase studies using monoclonal antibodies (MAb).
    Sobel RA; Blanchette BW; Colvin RB
    Prog Clin Biol Res; 1984; 146():81-6. PubMed ID: 6201925
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in clinico-immunological indices of experimental allergic encephalomyelitis after treatment with perftoran].
    Zhitnukhin IuL; Litvinenko IV; Bisaga GN; Odinak MM
    Biull Eksp Biol Med; 1997 Mar; 123(3):315-8. PubMed ID: 9162244
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of myelin lipids in experimental allergic encephalomyelitis.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Prog Clin Biol Res; 1984; 146():49-54. PubMed ID: 6201918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some immunological manifestations of experimental allergic encephalomyelitis (author's transl)].
    Rysková O; Nozicka Z; Vejbora O; Pekárek J
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jan; 31(1):21-9. PubMed ID: 6174247
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.
    Swanborg RH
    J Immunol; 1973 Oct; 111(4):1067-70. PubMed ID: 4728676
    [No Abstract]   [Full Text] [Related]  

  • 20. The blastoid transformation of the lymphocytes from experimental allergic encephalomyelitis guinea pigs.
    Nakano K; Nagai Y; Otani S; Tsumita T
    Jpn J Exp Med; 1971 Apr; 41(2):159-62. PubMed ID: 5313764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.